Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Perumalswami

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Racial and Ethnic Health Disparities|November 1, 2016
Hepatitis B and Hepatocellular Carcinoma Screening Practices in Chinese and African Immigrant-Rich Neighborhoods in New York CityS Fitzgerald, J Chao, Y Feferman, et al.
HIV Medicine|September 13, 2013
Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfectionV Martel-Laferrière, S Brinkley, K Bichoupan, et al.
Journal of Viral Hepatitis|May 15, 2018
Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: A surveillance-based propensity score matching approachR Deming, M M Ford, M S Moore, et al.
Journal of Viral Hepatitis|July 21, 2015
Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysisG N Nadkarni, A Patel, P K Simoes, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevirK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Racial and Ethnic Health Disparities|November 1, 2016
Hepatitis B and Hepatocellular Carcinoma Screening Practices in Chinese and African Immigrant-Rich Neighborhoods in New York CityS Fitzgerald, J Chao, Y Feferman, et al.
HIV Medicine|September 13, 2013
Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfectionV Martel-Laferrière, S Brinkley, K Bichoupan, et al.
Journal of Viral Hepatitis|May 15, 2018
Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: A surveillance-based propensity score matching approachR Deming, M M Ford, M S Moore, et al.
Journal of Viral Hepatitis|July 21, 2015
Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysisG N Nadkarni, A Patel, P K Simoes, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevirK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Pageof 1